These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15667475)

  • 1. Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction.
    Soldatos G; Sztal-Mazer S; Woolley I; Stockigt J
    Intern Med J; 2005 Jan; 35(1):67-8. PubMed ID: 15667475
    [No Abstract]   [Full Text] [Related]  

  • 2. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.
    Arrington-Sanders R; Hutton N; Siberry GK
    Pediatr Infect Dis J; 2006 Nov; 25(11):1044-8. PubMed ID: 17072128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritonavir and fluticasone: beware of this potentially fatal combination.
    Li AM
    J Pediatr; 2006 Mar; 148(3):294-5. PubMed ID: 16615953
    [No Abstract]   [Full Text] [Related]  

  • 4. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone.
    Johnson SR; Marion AA; Vrchoticky T; Emmanuel PJ; Lujan-Zilbermann J
    J Pediatr; 2006 Mar; 148(3):386-8. PubMed ID: 16615973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature.
    Foisy MM; Yakiwchuk EM; Chiu I; Singh AE
    HIV Med; 2008 Jul; 9(6):389-96. PubMed ID: 18459946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen.
    Clevenbergh P; Corcostegui M; Gérard D; Hieronimus S; Mondain V; Chichmanian RM; Sadoul JL; Dellamonica P
    J Infect; 2002 Apr; 44(3):194-5. PubMed ID: 12099750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of Kaposi sarcoma associated with iatrogenic Cushing syndrome in a person with HIV/AIDS.
    Jinno S; Goshima C
    AIDS Read; 2008 Feb; 18(2):100-4. PubMed ID: 18333287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing syndrome due to ritonavir-fluticasone interaction.
    Canalejo E; Pacheco MS
    CMAJ; 2012 Oct; 184(15):1714. PubMed ID: 22586335
    [No Abstract]   [Full Text] [Related]  

  • 9. [Exogenous Cushing's syndrome as a serious side-effect of therapy with ritonavir an inhaled fluticasone].
    Machala L; Kréze A; Jilich D; Rozsypal H
    Klin Mikrobiol Infekc Lek; 2011 Jun; 17(3):103-5. PubMed ID: 21780031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.
    Mahlab-Guri K; Asher I; Gradstein S; Zung A; Radian-Sade S; Elbirt D; Sthoeger Z
    J Asthma; 2011 Oct; 48(8):860-3. PubMed ID: 21854345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir.
    Bhumbra NA; Sahloff EG; Oehrtman SJ; Horner JM
    Ann Pharmacother; 2007 Jul; 41(7):1306-9. PubMed ID: 17535841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.
    Valin N; De Castro N; Garrait V; Bergeron A; Bouche C; Molina JM
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(2):113-21. PubMed ID: 19270151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent.
    St Germain RM; Yigit S; Wells L; Girotto JE; Salazar JC
    AIDS Patient Care STDS; 2007 Jun; 21(6):373-7. PubMed ID: 17594245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluticasone-ritonavir: a drug-drug interaction causing iatrogenic Cushing's syndrome and adrenal insufficiency].
    Rousseau C; Dolz M
    Med Mal Infect; 2014 Oct; 44(10):483-4. PubMed ID: 25282607
    [No Abstract]   [Full Text] [Related]  

  • 15. Ritonavir-induced Cushing's syndrome in a patient treated with nasal fluticasone.
    Hillebrand-Haverkort ME; Prummel MF; ten Veen JH
    AIDS; 1999 Sep; 13(13):1803. PubMed ID: 10509596
    [No Abstract]   [Full Text] [Related]  

  • 16. Ritonavir-dependent fluconazole boosting of nelfinavir: a report of three cases.
    Garazzino S; Tettoni M; Calcagno A; D'Avolio A; Bonora S; Di Perri G
    J Antimicrob Chemother; 2006 Aug; 58(2):483-5. PubMed ID: 16751639
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled corticosteroids in persons with HIV infection: not that harmless.
    Spruyt S; Vlieghe E; Bomans P; Moerman F; Colebunders R; Van den Ende J
    Acta Clin Belg; 2012; 67(2):120-2. PubMed ID: 22712167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophy.
    Gupta SK; Dubé MP
    Clin Infect Dis; 2002 Sep; 35(6):E69-71. PubMed ID: 12203188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal insufficiency and exogenous Cushing's syndrome in a patient receiving inhaled fluticasone and ritonavir.
    Zubillaga I; Francés C; Nicolau J; Homar F; Masmiquel L
    Endocrinol Diabetes Nutr; 2017; 64(6):338-339. PubMed ID: 29056281
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between fosamprenavir, with and without ritonavir, and nevirapine in human immunodeficiency virus-infected subjects.
    DeJesus E; Piliero PJ; Summers K; Wire MB; Stein DS; Masterman A; Lou Y; Min SS; Shelton MJ
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3157-9. PubMed ID: 16940117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.